AVITA Medical (RCEL) Equity Average (2020 - 2025)
Historic Equity Average for AVITA Medical (RCEL) over the last 6 years, with Q4 2025 value amounting to -$11.7 million.
- AVITA Medical's Equity Average fell 23939.97% to -$11.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$11.7 million, marking a year-over-year decrease of 23939.97%. This contributed to the annual value of -$6.1 million for FY2025, which is 12268.88% down from last year.
- Per AVITA Medical's latest filing, its Equity Average stood at -$11.7 million for Q4 2025, which was down 23939.97% from -$9.8 million recorded in Q3 2025.
- In the past 5 years, AVITA Medical's Equity Average ranged from a high of $117.3 million in Q2 2021 and a low of -$11.7 million during Q4 2025
- In the last 5 years, AVITA Medical's Equity Average had a median value of $69.5 million in 2023 and averaged $57.1 million.
- In the last 5 years, AVITA Medical's Equity Average surged by 7277.53% in 2021 and then plummeted by 23939.97% in 2025.
- Quarter analysis of 5 years shows AVITA Medical's Equity Average stood at $108.1 million in 2021, then decreased by 20.08% to $86.4 million in 2022, then crashed by 35.14% to $56.0 million in 2023, then plummeted by 85.07% to $8.4 million in 2024, then tumbled by 239.4% to -$11.7 million in 2025.
- Its Equity Average was -$11.7 million in Q4 2025, compared to -$9.8 million in Q3 2025 and -$8.7 million in Q2 2025.